Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Avanti

K-Number: K180660 · 2018-06-08

ApplicantOptovue, Inc.
Decision Date2018-06-08
Product CodeOBO
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

Avanti is the device name listed in this FDA 510(k) record. The listed applicant is Optovue, Inc.. It received FDA 510(k) clearance on 2018-06-08 under 510(k) number K180660. The device is classified under product code OBO. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Avanti?

Avanti is a medical device that received FDA 510(k) clearance on 2018-06-08. The listed applicant is Optovue, Inc.. The 510(k) number is K180660.

When did Avanti receive FDA 510(k) clearance?

Avanti received FDA 510(k) clearance on 2018-06-08, under 510(k) number K180660.

Who is the listed applicant for Avanti?

The FDA 510(k) record lists Optovue, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Avanti?

The FDA product code for Avanti is OBO.

Other records listing Optovue, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: OBO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.